Subcutaneous Tarlatamab in Subjects with Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511838-12-00

Acronym

20230298

Enrollment

Registered

2024-10-21

Start date

2024-11-22

Completion date

Unknown

Last updated

2025-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Germany, Poland, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026